(R)-Methyl morpholine-3-carboxylate hydrochloride, 95.0%, 5g

N,N-Dimethyl-3-nitropyridin-2-amine, 95.0%, 25g

4-(2-bromobenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

5,7-DICHLORO-2-ETHYL-2H-PYRAZOLO[4,3-D]PYRIMIDINE, 95.0%, 1g

3-Benzofurancarboxylic acid, 4-[(1E)-3-[(1R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxo-1-propen-1-yl]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-, (2S,3S)-, 95%, 100mg

Heptanal>95.0%(GC)500mL

(S)-1-(tert-Butoxycarbonyl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid, 95.0%, 5g

Bromuro de potasio, mínimo 98%, Ph.Eur., 250 g, envase de plástico.

RuCl2[(R)-xylbinap][(R)-daipen]1g

Tapón de rosca HPLC b.safe GL 45 con dos conexiones, 1 pieza

9-Benzyl-3,6-dibromocarbazole>98.0%(GC)(N)1g

4,6-Dimethylpyridine-2,3-diamine, 95.0%, 1g

N,N'-Difluoro-2,2'-bipyridiniumbis(tetrafluoroborate), 95.0%, 1g